Cwm, LLC Editas Medicine, Inc. Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Cwm, LLC holds 44,628 shares of EDIT stock, worth $134,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,628

Previous 44,337 0.66%

Holding current value

$134,330

Previous $98,000 58.16%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$2.2 - $3.52 $640 - $1,024	291 Added 0.66%	44,628 $155,000
Q2 2025 Jul 25, 2025	SELL	$0.98 - $2.35 $2,899 - $6,953	-2,959 Reduced 6.26%	44,337 $98,000
Q1 2025 May 01, 2025	BUY	$1.14 - $3.2 $36,998 - $103,856	32,455 Added 218.68%	47,296 $55,000
Q4 2024 Feb 04, 2025	BUY	$1.2 - $3.76 $8,206 - $25,714	6,839 Added 85.47%	14,841 $19,000
Q3 2024 Oct 08, 2024	BUY	$3.39 - $5.96 $25,380 - $44,622	7,487 Added 1453.79%	8,002 $27,000
Q2 2024 Jul 09, 2024	SELL	$4.67 - $7.28 $126 - $196	-27 Reduced 4.98%	515 $2,000
Q1 2024 Apr 05, 2024	BUY	$7.03 - $11.07 $112 - $177	16 Added 3.04%	542 $4,000
Q4 2023 Feb 01, 2024	BUY	$6.25 - $11.11 $206 - $366	33 Added 6.69%	526 $5,000
Q3 2023 Oct 11, 2023	BUY	$6.92 - $9.31 $477 - $642	69 Added 16.27%	493 $4,000
Q2 2023 Aug 03, 2023	SELL	$6.36 - $11.47 $623 - $1,124	-98 Reduced 18.77%	424 $3,000
Q1 2023 Apr 28, 2023	BUY	$7.03 - $11.53 $1,680 - $2,755	239 Added 84.45%	522 $4,000
Q2 2022 Jul 28, 2022	SELL	$9.99 - $21.35 $1,288 - $2,754	-129 Reduced 31.31%	283 $3,000
Q1 2022 Apr 21, 2022	SELL	$14.08 - $27.63 $10,320 - $20,252	-733 Reduced 64.02%	412 $8,000
Q4 2021 Jan 31, 2022	BUY	$26.55 - $40.57 $955 - $1,460	36 Added 3.25%	1,145 $30,000
Q1 2021 Sep 15, 2021	BUY	$39.71 - $90.58 $953 - $2,173	24 Added 2.21%	1,109 $63,000
Q1 2021 Apr 27, 2021	SELL	$39.71 - $90.58 $953 - $2,173	-24 Reduced 2.16%	1,085 $46,000
Q4 2020 Sep 15, 2021	BUY	$27.07 - $84.35 $27,719 - $86,374	1,024 Added 1204.71%	1,109 $63,000
Q4 2020 Jan 27, 2021	SELL	$27.07 - $84.35 $27,719 - $86,374	-1,024 Reduced 92.34%	85 $6,000
Q3 2020 Sep 15, 2021	BUY	$28.06 - $37.16 $28,733 - $38,051	1,024 Added 1204.71%	1,109 $63,000
Q3 2020 Oct 19, 2020	SELL	$28.06 - $37.16 $28,733 - $38,051	-1,024 Reduced 92.34%	85 $2,000
Q2 2020 Sep 15, 2021	BUY	$18.5 - $34.34 $16,021 - $29,738	866 Added 356.38%	1,109 $63,000
Q2 2020 Jul 22, 2020	SELL	$18.5 - $34.34 $16,021 - $29,738	-866 Reduced 78.09%	243 $7,000
Q1 2020 Sep 15, 2021	BUY	$14.88 - $32.78 $14,121 - $31,108	949 Added 593.13%	1,109 $63,000
Q1 2020 Apr 28, 2020	SELL	$14.88 - $32.78 $14,121 - $31,108	-949 Reduced 85.57%	160 $3,000
Q4 2019 Sep 14, 2021	BUY	$19.49 - $32.63 $18,496 - $30,965	949 Added 593.13%	1,109 $63,000
Q4 2019 Jan 27, 2020	SELL	$19.49 - $32.63 $18,496 - $30,965	-949 Reduced 85.57%	160 $5,000
Q3 2019 Sep 14, 2021	BUY	$22.49 - $26.81 $24,941 - $29,732	1,109 New	1,109 $63,000
Q3 2019 Oct 22, 2019	SELL	$22.49 - $26.81 $24,941 - $29,732	-1,109 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$20.48 - $27.76 $22,712 - $30,785	1,109 New	1,109 $63,000
Q2 2019 Jul 31, 2019	SELL	$20.48 - $27.76 $22,712 - $30,785	-1,109 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$19.43 - $26.41 $21,547 - $29,288	1,109 New	1,109 $0

Others Institutions Holding EDIT

# of Institutions

215

Shares Held

45.4M

Call Options Held

476K

Put Options Held

338K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $207M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account